Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726345 | SCV000343961 | uncertain significance | not provided | 2016-08-26 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000325214 | SCV000712617 | likely benign | not specified | 2016-11-15 | criteria provided, single submitter | clinical testing | p.Val10277Val in exon 147 of TTN: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. |
Invitae | RCV001085747 | SCV001013321 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-19 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486810 | SCV004239893 | likely benign | Cardiomyopathy | 2023-05-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003920154 | SCV004734317 | likely benign | TTN-related condition | 2019-08-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |